Company intelligence / Profile preview
Acura Pharmaceuticals, Inc.
Palatine, Illinois, United Statesacurapharm.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Other
01
Overview
Acura has commercialized products including OXAYDO® (oxycodone HCl) and Nexafed® (pseudoephedrine HCl). Their lead product in development is LTX-03 (hydrocodone bitartrate and acetaminophen) using their LIMITX™ technology.
- Therapeutic areas
- PulmonologyNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Zyla Life Sciences (formerly Egalet Corporation)MainPointe Pharmaceuticals LLCAbuse Deterrent Pharmaceuticals LLCKing Pharmaceuticals (subsidiary of Pfizer, Inc.)
Beyond the preview
Go deeper on Acura Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acura Pharmaceuticals, Inc..